X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AMAR REMEDIES with Marico Ltd - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AMAR REMEDIES vs MARICO LTD - Comparison Results

MARICO LTD 
   Change

Marico derives 72% of its domestic revenues from edible oil and 20% from hair oils. It has two well-known domestic brands Parachute and Saffola and has acquired a clutch of international personal care brands such as 'Camelia', 'Aromatic' and 'Magnoli... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AMAR REMEDIES MARICO LTD AMAR REMEDIES/
MARICO LTD
 
P/E (TTM) x -0.5 51.3 - View Chart
P/BV x 0.1 17.3 0.3% View Chart
Dividend Yield % 0.0 1.1 -  

Financials

 AMAR REMEDIES   MARICO LTD
EQUITY SHARE DATA
    AMAR REMEDIES
Jun-12
MARICO LTD
Mar-17
AMAR REMEDIES/
MARICO LTD
5-Yr Chart
Click to enlarge
High Rs164307 53.4%   
Low Rs86235 36.7%   
Sales per share (Unadj.) Rs261.645.9 570.5%  
Earnings per share (Unadj.) Rs17.46.3 276.8%  
Cash flow per share (Unadj.) Rs22.37.0 319.1%  
Dividends per share (Unadj.) Rs03.50 0.0%  
Dividend yield (eoy) %01.3 0.0%  
Book value per share (Unadj.) Rs100.718.0 558.9%  
Shares outstanding (eoy) m26.161,290.47 2.0%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x0.55.9 8.1%   
Avg P/E ratio x7.243.1 16.7%  
P/CF ratio (eoy) x5.638.8 14.5%  
Price / Book Value ratio x1.215.0 8.3%  
Dividend payout %055.7 0.0%   
Avg Mkt Cap Rs m3,270349,395 0.9%   
No. of employees `000NA1.6 0.0%   
Total wages/salary Rs m1634,042 4.0%   
Avg. sales/employee Rs ThNM37,265.7-  
Avg. wages/employee Rs ThNM2,545.2-  
Avg. net profit/employee Rs ThNM5,106.9-  
INCOME DATA
Net Sales Rs m6,84459,178 11.6%  
Other income Rs m21973 2.2%   
Total revenues Rs m6,86560,151 11.4%   
Gross profit Rs m1,13111,593 9.8%  
Depreciation Rs m128903 14.2%   
Interest Rs m398166 240.0%   
Profit before tax Rs m62611,497 5.4%   
Minority Interest Rs m0-10 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-500-   
Tax Rs m1213,377 3.6%   
Profit after tax Rs m4558,110 5.6%  
Gross profit margin %16.519.6 84.4%  
Effective tax rate %19.329.4 65.8%   
Net profit margin %6.613.7 48.5%  
BALANCE SHEET DATA
Current assets Rs m4,90423,818 20.6%   
Current liabilities Rs m3,58112,226 29.3%   
Net working cap to sales %19.319.6 98.7%  
Current ratio x1.41.9 70.3%  
Inventory Days Days12477 160.7%  
Debtors Days Days10015 657.5%  
Net fixed assets Rs m1,6895,883 28.7%   
Share capital Rs m2621,291 20.3%   
"Free" reserves Rs m2,35821,966 10.7%   
Net worth Rs m2,63523,257 11.3%   
Long term debt Rs m5070-   
Total assets Rs m6,86235,995 19.1%  
Interest coverage x2.670.3 3.7%   
Debt to equity ratio x0.20-  
Sales to assets ratio x1.01.6 60.7%   
Return on assets %12.423.0 54.1%  
Return on equity %17.334.9 49.5%  
Return on capital %31.050.1 61.9%  
Exports to sales %4.00-   
Imports to sales %00-   
Exports (fob) Rs m273NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m2734,190 6.5%   
Fx outflow Rs m22,399 0.1%   
Net fx Rs m2711,791 15.1%   
CASH FLOW
From Operations Rs m-3136,116 -5.1%  
From Investments Rs m-489-630 77.5%  
From Financial Activity Rs m769-5,740 -13.4%  
Net Cashflow Rs m-33-592 5.5%  

Share Holding

Indian Promoters % 25.5 59.6 42.8%  
Foreign collaborators % 0.0 0.1 -  
Indian inst/Mut Fund % 9.2 2.6 353.8%  
FIIs % 0.0 31.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 65.3 6.7 974.6%  
Shareholders   13,061 37,128 35.2%  
Pledged promoter(s) holding % 99.7 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AMAR REMEDIES With:   GILLETTE INDIA  ARCHIES LTD  K.S.OILS LTD  BAJAJ CORP  KARUTURI GLOBAL  

Compare AMAR REMEDIES With:   P&G (US)  UNILEVER PLC. (UK)  HYPERMARCAS (Brazil)  



Today's Market

Sensex Trades on a Volatile Note; Airtel, Idea Down by 5%(01:30 pm)

After opening the day in green share markets in India witnessed choppy trading activity and are presently trading above the dotted line.

Related Views on News

Marico: Earnings Hit by Lower Volumes and Firming Input Prices (Quarterly Results Update - Detailed)

Aug 9, 2017

While GST implementation brought down volumes and profitability in the short run, Marico remains optimistic in the long run.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

More Views on News

Most Popular

Mutual Funds Clearly Tell Us That There is a Bubble in the Stock Market(Vivek Kaul's Diary)

Jan 11, 2018

The maximum amount of money ever has come into equity mutual funds during the current financial year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Nirvana denied: Has Value Failed?(The Honest Truth)

Jan 13, 2018

Should investors choose growth over value this year?

'Smart Money' Enters Bitcoin. Will You?(Smart Contrarian)

Jan 17, 2018

As institutional money enters bitcoin, the gains over the last year could just be the tip of the iceberg.

Increasing Divergence Between Bond Yields and Earnings Yield(Chart Of The Day)

Jan 11, 2018

Over the past couple of months, bond yields have risen, but earning yields have fallen, increasing divergence.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

AMAR REMEDIES SHARE PRICE


Dec 11, 2013 (Close)

TRACK AMAR REMEDIES

  • Track your investment in AMAR REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AMAR REMEDIES - RELAXO FOOTWEARS COMPARISON

COMPARE AMAR REMEDIES WITH

MARKET STATS